KindlyMD’s Bitcoin Stock Plummets 10% After Earnings Delay: What’s Behind the Nakamoto Merger Fallout?

KindlyMD’s stock fell nearly 10% after missing its earnings deadline due to accounting issues.
Close-up of a golden Bitcoin coin against a vibrant purple and pink upward-trending line graph. Close-up of a golden Bitcoin coin against a vibrant purple and pink upward-trending line graph.
A physical Bitcoin coin is centered against a vibrant line graph suggesting an upward market trend. By MDL.

KindlyMD, a Bitcoin treasury firm trading on the Nasdaq under the ticker NAKA, saw its stock price fall nearly 10% on Monday after the company announced it would miss its third-quarter earnings deadline. The firm cited complex accounting related to its merger with Nakamoto as the reason for the delay, with shares now down more than 95% from six months ago.

Earnings Delay and Market Reaction

The company’s shares dropped to $0.55 by the end of Monday’s trading day, marking a 25% decline over the past week. KindlyMD, like other U.S. publicly traded companies, had a November 14 deadline to file its Q3 earnings report, which covers the period ending September 30.

Instead of its 10-Q report, KindlyMD filed paperwork with the U.S. Securities and Exchange Commission (SEC) on Friday. The filing stated that the intricacies of accounting stemming from its merger with Nakamoto “necessitated additional time to ensure the accuracy and completeness of the information.” Earlier this year, KindlyMD merged with Nakamoto, a Bitcoin treasury firm previously known as Nakamoto Games, leading to Nakamoto founder David Bailey being appointed CEO in August.

Anticipated Financial Impacts

The firm indicated in its filing that its upcoming Q3 numbers would reflect a “significant change” compared to the previous year. KindlyMD expects to report a $59 million loss on the Nakamoto acquisition, a $1.4 million realized loss from selling digital assets, and an unrealized loss exceeding $22 million on its remaining digital asset holdings. Additionally, a $14.4 million loss on the extinguishment of debt is anticipated.

Despite these significant losses, KindlyMD also projects a $21.8 million positive change in the fair value of contingent liability. This gain results from a markdown in the value of one of the company’s liabilities, which will be reflected positively in its earnings report.

Market Outlook

The delay in KindlyMD’s earnings report and the forecast of substantial losses highlight the financial complexities following its merger with Nakamoto, contributing to a dramatic decline in its stock performance over recent months.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Secret Link